“340B Drug Discount Program Should Be on GAO’s High-Risk List”
When a new Congress begins, the Government Accountability Office (GAO) releases its updated “High-Risk List” of programs and operations that […]
340B In The News
“Congress Must Ensure Patients, Not Corporations, Benefit from 340B Drug Program”
With the expansion of coverage of healthcare in 2010 through the Affordable Care Act, much changed in our efforts to
“It’s time to reevaluate 340B intermediary relationships and ask who they serve”
Citing compliance concerns, specifically duplicate discounts, several drug manufacturers took steps to reduce contract pharmacy access to 340B-priced drugs. The
“To Keep Drug Costs Down and Fairness Up, Stop the Abuses of 340B”
Alas, hospitals and pharmacies are abusing a federal program meant to help low-income patients. New research from consulting firm Berkeley
“340B Program Should Be Kept & Corrected”
With the election behind us, I’m glad that our elected leaders can stop focusing on getting elected and start focusing
“Discount drug plan needs congressional reform”
In the 340B program, drug manufacturers provide medications at steep discounts, with the intent of those discounts being passed along
“Federally qualified health centers help Merced patients with medication costs”
Federally qualified health centers help Merced patients with medication costs
“Problems Continue with 340B Program”
Citizens Against Government Waste has been critical of the 340B drug discount program for several years and has called for
“A Few Bad Apples Destroying a Vital Drug Program for the Underserved”
COVID-19 has swept through the United States, leaving death and devastation in its wake and preying on vulnerable populations the
“Double-dippers drive up drug costs”
In searching for answers to why drug costs are high, we only need look at problems our own government has